Literature DB >> 35618573

Cellular and molecular mechanisms of plasticity in cancer.

Stefan R Torborg1, Zhuxuan Li2, Jason E Chan3, Tuomas Tammela4.   

Abstract

Cancer cells are plastic - they can assume a wide range of distinct phenotypes. Plasticity is integral to cancer initiation and progression, as well as to the emergence and maintenance of intratumoral heterogeneity. Furthermore, plastic cells can rapidly adapt to and evade therapy, which poses a challenge for effective cancer treatment. As such, targeting plasticity in cancer holds tremendous promise. Yet, the principles governing plasticity in cancer cells remain poorly understood. Here, we provide an overview of the fundamental molecular and cellular mechanisms that underlie plasticity in cancer and in other biological contexts, including development and regeneration. We propose a key role for high-plasticity cell states (HPCSs) as crucial nodes for cell state transitions and enablers of intra-tumoral heterogeneity.
Copyright © 2022 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  cancer therapy; cell state transition; differentiation; intratumoral heterogeneity; plasticity; tumor evolution

Mesh:

Substances:

Year:  2022        PMID: 35618573      PMCID: PMC9388572          DOI: 10.1016/j.trecan.2022.04.007

Source DB:  PubMed          Journal:  Trends Cancer        ISSN: 2405-8025


  96 in total

Review 1.  Basic and therapeutic aspects of angiogenesis.

Authors:  Michael Potente; Holger Gerhardt; Peter Carmeliet
Journal:  Cell       Date:  2011-09-16       Impact factor: 41.582

Review 2.  Extrachromosomal oncogene amplification in tumour pathogenesis and evolution.

Authors:  Roel G W Verhaak; Vineet Bafna; Paul S Mischel
Journal:  Nat Rev Cancer       Date:  2019-05       Impact factor: 60.716

3.  Signatures of plasticity, metastasis, and immunosuppression in an atlas of human small cell lung cancer.

Authors:  Joseph M Chan; Álvaro Quintanal-Villalonga; Vianne Ran Gao; Yubin Xie; Viola Allaj; Ojasvi Chaudhary; Ignas Masilionis; Jacklynn Egger; Andrew Chow; Thomas Walle; Marissa Mattar; Dig V K Yarlagadda; James L Wang; Fathema Uddin; Michael Offin; Metamia Ciampricotti; Besnik Qeriqi; Amber Bahr; Elisa de Stanchina; Umesh K Bhanot; W Victoria Lai; Matthew J Bott; David R Jones; Arvin Ruiz; Marina K Baine; Yanyun Li; Natasha Rekhtman; John T Poirier; Tal Nawy; Triparna Sen; Linas Mazutis; Travis J Hollmann; Dana Pe'er; Charles M Rudin
Journal:  Cancer Cell       Date:  2021-10-14       Impact factor: 31.743

4.  The Stress-Like Cancer Cell State Is a Consistent Component of Tumorigenesis.

Authors:  Maayan Baron; Mohita Tagore; Miranda V Hunter; Isabella S Kim; Reuben Moncada; Yun Yan; Nathaniel R Campbell; Richard M White; Itai Yanai
Journal:  Cell Syst       Date:  2020-09-09       Impact factor: 10.304

5.  Dedifferentiation of neurons and astrocytes by oncogenes can induce gliomas in mice.

Authors:  Dinorah Friedmann-Morvinski; Eric A Bushong; Eugene Ke; Yasushi Soda; Tomotoshi Marumoto; Oded Singer; Mark H Ellisman; Inder M Verma
Journal:  Science       Date:  2012-10-18       Impact factor: 47.728

Review 6.  Phenotype plasticity as enabler of melanoma progression and therapy resistance.

Authors:  Imanol Arozarena; Claudia Wellbrock
Journal:  Nat Rev Cancer       Date:  2019-06-17       Impact factor: 60.716

7.  Fat1 deletion promotes hybrid EMT state, tumour stemness and metastasis.

Authors:  Ievgenia Pastushenko; Federico Mauri; Yura Song; Florian de Cock; Bob Meeusen; Benjamin Swedlund; Francis Impens; Delphi Van Haver; Matthieu Opitz; Manuel Thery; Yacine Bareche; Gaelle Lapouge; Marjorie Vermeersch; Yves-Rémi Van Eycke; Cédric Balsat; Christine Decaestecker; Youri Sokolow; Sergio Hassid; Alicia Perez-Bustillo; Beatriz Agreda-Moreno; Luis Rios-Buceta; Pedro Jaen; Pedro Redondo; Ramon Sieira-Gil; Jose F Millan-Cayetano; Onofre Sanmatrtin; Nicky D'Haene; Virginie Moers; Milena Rozzi; Jeremy Blondeau; Sophie Lemaire; Samuel Scozzaro; Veerle Janssens; Magdalena De Troya; Christine Dubois; David Pérez-Morga; Isabelle Salmon; Christos Sotiriou; Francoise Helmbacher; Cédric Blanpain
Journal:  Nature       Date:  2020-12-16       Impact factor: 49.962

Review 8.  The MYC oncogene - the grand orchestrator of cancer growth and immune evasion.

Authors:  Renumathy Dhanasekaran; Anja Deutzmann; Wadie D Mahauad-Fernandez; Aida S Hansen; Arvin M Gouw; Dean W Felsher
Journal:  Nat Rev Clin Oncol       Date:  2021-09-10       Impact factor: 66.675

9.  A restricted cell population propagates glioblastoma growth after chemotherapy.

Authors:  Jian Chen; Yanjiao Li; Tzong-Shiue Yu; Renée M McKay; Dennis K Burns; Steven G Kernie; Luis F Parada
Journal:  Nature       Date:  2012-08-23       Impact factor: 49.962

10.  A slow-cycling LGR5 tumour population mediates basal cell carcinoma relapse after therapy.

Authors:  Adriana Sánchez-Danés; Jean-Christophe Larsimont; Mélanie Liagre; Eva Muñoz-Couselo; Gaëlle Lapouge; Audrey Brisebarre; Christine Dubois; Mariano Suppa; Vijayakumar Sukumaran; Véronique Del Marmol; Josep Tabernero; Cédric Blanpain
Journal:  Nature       Date:  2018-10-08       Impact factor: 49.962

View more
  1 in total

1.  Systematic Comparison of Pancreatic Ductal Adenocarcinoma Models Identifies a Conserved Highly Plastic Basal Cell State.

Authors:  Kenneth L Pitter; Olivera Grbovic-Huezo; Simon Joost; Anupriya Singhal; Melissa Blum; Katherine Wu; Matilda Holm; Alexander Ferrena; Arjun Bhutkar; Anna Hudson; Nicolas Lecomte; Elisa de Stanchina; Ronan Chaligne; Christine A Iacobuzio-Donahue; Dana Pe'er; Tuomas Tammela
Journal:  Cancer Res       Date:  2022-10-04       Impact factor: 13.312

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.